SDC1 and Miyoshi myopathy: We tried to shed light on the expression of PD1 and CD138+ microparticles in MM and their possible interplay as a mechanism of resistance to standardized treatments by proteasome inhibitors and immunomodulatory drugs, in addition, find their associations with other prognostic factors of symptomatic MM.